BF Biosciences Ltd (BFBI)

Currency in PKR
155.00
-1.14(-0.73%)
Closed·
BFBI Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
BFBI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
154.00158.00
52 wk Range
87.00253.97
Key Statistics
Bid/Ask
155.31 / 155.00
Prev. Close
156.14
Open
157
Day's Range
154-158
52 wk Range
87-253.97
Volume
162.65K
Average Volume (3m)
750.64K
1-Year Change
82.48%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BFBI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

BF Biosciences Ltd Company Profile

BF Biosciences Limited, a biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products in Pakistan, Nepal, Afghanistan, Mauritania, Switzerland, and internationally. The company offers pharmaceutical products for various therapeutic areas, including cardiometabolic disorders, cardiology, diabetes, anti-obesity, hepatology, gastroenterology, chronic kidney diseases, dermatology, antifungal treatments, antibiotics, antivirals, rheumatoid arthritis, nephrology, and oncology. It also provides injectables in vials, ampoules, and pre-filled syringes forms. In addition, the company is involved in the sale of medical devices; and toll manufacturing services for pharmaceutical products to other pharmaceutical companies. It exports its products. The company was incorporated in 2006 and is headquartered in Lahore, Pakistan. BF Biosciences Limited is a subsidiary of Ferozsons Laboratories Limited.

Employees
535
Market
Pakistan

Compare BFBI to Peers and Sector

Metrics to compare
BFBI
Peers
Sector
Relationship
P/E Ratio
30.6x19.2x−0.7x
PEG Ratio
−3.320.170.00
Price/Book
2.9x2.1x2.6x
Price / LTM Sales
2.3x1.6x3.4x
Upside (Analyst Target)
−9.7%42.1%37.6%
Fair Value Upside
Unlock14.6%4.6%Unlock

Earnings

Latest Release
Sep 03, 2025
EPS / Forecast
1.43 / --
Revenue / Forecast
1.62B / --
EPS Revisions
Last 90 days

BFBI Income Statement

People Also Watch

214.62
ENGR
-2.17%
477.28
FAUF
-0.15%
88.85
CITI
-0.72%
1,880.00
SAZG
-0.40%

FAQ

What Stock Exchange Does BF Biosciences Trade On?

BF Biosciences is listed and trades on the Karachi Stock Exchange stock exchange.

What Is the Stock Symbol for BF Biosciences?

The stock symbol for BF Biosciences is "BFBI."

What Is the BF Biosciences Market Cap?

As of today, BF Biosciences market cap is 13.74B.

What Is BF Biosciences's Earnings Per Share (TTM)?

The BF Biosciences EPS (TTM) is 5.52.

When Is the Next BF Biosciences Earnings Date?

BF Biosciences will release its next earnings report on 02 Dec 2025.

From a Technical Analysis Perspective, Is BFBI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BF Biosciences Stock Split?

BF Biosciences has split 0 times.

How Many Employees Does BF Biosciences Have?

BF Biosciences has 535 employees.

What is the current trading status of BF Biosciences (BFBI)?

As of 25 Oct 2025, BF Biosciences (BFBI) is trading at a price of 155.00, with a previous close of 156.14. The stock has fluctuated within a day range of 154.00 to 158.00, while its 52-week range spans from 87.00 to 253.97.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.